(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:735755 6480464 epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in decreased expression of SFRP1 mRNA], epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in decreased expression of SFRP1 protein] CTD PMID:27058323 1,1-dichloroethene decreases expression ISO RGD:735755 6480464 vinylidene chloride results in decreased expression of SFRP1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:735755 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of SFRP1 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:735755 6480464 1, 2-Dimethylhydrazine results in decreased expression of SFRP1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of SFRP1 mRNA CTD PMID:30723492 17alpha-ethynylestradiol affects expression ISO RGD:735755 6480464 Ethinyl Estradiol affects the expression of SFRP1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of SFRP1 mRNA CTD PMID:16174780 17alpha-ethynylestradiol decreases expression ISO RGD:735755 6480464 Ethinyl Estradiol results in decreased expression of SFRP1 mRNA CTD PMID:16174780 17beta-estradiol increases expression ISO RGD:735755 6480464 Estradiol results in increased expression of SFRP1 mRNA CTD PMID:19484750 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:735755 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:735755 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:735755 6480464 AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of SFRP1 mRNA] CTD PMID:19759094 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SFRP1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735755 6480464 Tetrachlorodibenzodioxin affects the expression of SFRP1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:735755 6480464 Tetrachlorodibenzodioxin results in decreased expression of SFRP1 mRNA CTD PMID:19759094 , PMID:33956508 2-hydroxypropanoic acid decreases expression ISO RGD:735754 6480464 Lactic Acid results in decreased expression of SFRP1 mRNA CTD PMID:30851411 3-aminobenzamide multiple interactions EXP 6480464 3-aminobenzamide inhibits the reaction [SFRP1 protein promotes the reaction [Doxorubicin results in increased cleavage of CASP3 protein]] CTD PMID:30377735 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:735755 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of SFRP1 mRNA CTD PMID:16054899 3-methylcholanthrene multiple interactions ISO RGD:735755 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SFRP1 mRNA CTD PMID:23519560 3-Nitrobenzanthrone increases expression ISO RGD:735754 6480464 3-nitrobenzanthrone results in increased expression of SFRP1 mRNA CTD PMID:34036453 4,4'-sulfonyldiphenol decreases methylation ISO RGD:735755 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of SFRP1 exon CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:735755 6480464 Fenretinide results in increased expression of SFRP1 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression ISO RGD:735755 6480464 Fenretinide results in decreased expression of SFRP1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions ISO RGD:735754 6480464 [Decitabine affects the methylation of SFRP1 promoter] which affects the expression of SFRP1 mRNA, [Decitabine co-treated with trichostatin A] results in increased expression of SFRP1 mRNA CTD PMID:17923031 , PMID:18283316 5-aza-2'-deoxycytidine affects expression ISO RGD:735754 6480464 Decitabine affects the expression of SFRP1 mRNA CTD PMID:18538736 5-aza-2'-deoxycytidine increases expression ISO RGD:735754 6480464 Decitabine results in increased expression of SFRP1 mRNA CTD PMID:19234609 , PMID:19387464 5-aza-2'-deoxycytidine affects methylation ISO RGD:735754 6480464 Decitabine affects the methylation of SFRP1 promoter CTD PMID:17882284 5-aza-2'-deoxycytidine decreases methylation ISO RGD:735754 6480464 Decitabine results in decreased methylation of SFRP1 promoter CTD PMID:19387464 5-formyltetrahydrofolic acid multiple interactions EXP 6480464 Leucovorin inhibits the reaction [Methotrexate results in increased expression of SFRP1 mRNA], Leucovorin inhibits the reaction [Methotrexate results in increased expression of SFRP1 protein] CTD PMID:25187349 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SFRP1 mRNA CTD PMID:24780913 , PMID:30047161 8-Br-cAMP increases expression ISO RGD:735754 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SFRP1 mRNA CTD PMID:20147733 , PMID:22079614 acetamide increases expression EXP 6480464 acetamide results in increased expression of SFRP1 mRNA CTD PMID:31881176 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SFRP1 mRNA CTD PMID:25378103 Aflatoxin B2 alpha increases methylation ISO RGD:735754 6480464 aflatoxin B2 results in increased methylation of SFRP1 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:735754 6480464 Tretinoin results in decreased expression of SFRP1 mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression ISO RGD:735754 6480464 Tretinoin results in increased expression of SFRP1 mRNA CTD PMID:23724009 amitrole increases expression EXP 6480464 Amitrole results in increased expression of SFRP1 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SFRP1 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:735754 6480464 Antirheumatic Agents results in decreased expression of SFRP1 mRNA CTD PMID:24449571 arsane multiple interactions ISO RGD:735754 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SFRP1 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:735754 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SFRP1 mRNA CTD PMID:32525701 arsenous acid increases expression ISO RGD:735754 6480464 Arsenic Trioxide results in increased expression of SFRP1 mRNA, Arsenic Trioxide results in increased expression of SFRP1 protein CTD PMID:26966376 , PMID:28565807 arsenous acid decreases methylation ISO RGD:735754 6480464 Arsenic Trioxide results in decreased methylation of SFRP1 gene, Arsenic Trioxide results in decreased methylation of SFRP1 promoter CTD PMID:26966376 , PMID:28565807 atrazine increases expression ISO RGD:735754 6480464 Atrazine results in increased expression of SFRP1 mRNA CTD PMID:22378314 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of SFRP1 gene CTD PMID:35440735 benzo[a]pyrene decreases expression ISO RGD:735755 6480464 Benzo(a)pyrene results in decreased expression of SFRP1 mRNA CTD PMID:21803694 benzo[a]pyrene increases methylation ISO RGD:735755 6480464 Benzo(a)pyrene results in increased methylation of SFRP1 intron CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:735754 6480464 Benzo(a)pyrene affects the methylation of SFRP1 3' UTR, Benzo(a)pyrene affects the methylation of SFRP1 promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:735754 6480464 Benzo(a)pyrene results in decreased methylation of SFRP1 exon CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of SFRP1 mRNA CTD PMID:21839799 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SFRP1 mRNA CTD PMID:18164116 beta-naphthoflavone decreases expression ISO RGD:735754 6480464 beta-Naphthoflavone results in decreased expression of SFRP1 mRNA CTD PMID:32858204 biguanides affects expression ISO RGD:735754 6480464 Biguanides analog affects the expression of SFRP1 mRNA CTD PMID:17463086 bisphenol A decreases expression ISO RGD:735754 6480464 bisphenol A results in decreased expression of SFRP1 mRNA CTD PMID:22576693 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SFRP1 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:735754 6480464 bisphenol A results in increased methylation of SFRP1 gene CTD PMID:22576693 bleomycin A2 increases expression ISO RGD:735755 6480464 Bleomycin results in increased expression of SFRP1 mRNA CTD PMID:26345256 boron nitride decreases expression ISO RGD:735754 6480464 boron nitride results in decreased expression of SFRP1 mRNA CTD PMID:30644070 cadmium dichloride increases expression ISO RGD:735754 6480464 Cadmium Chloride results in increased expression of SFRP1 mRNA CTD PMID:21457566 caffeine multiple interactions EXP 6480464 Caffeine inhibits the reaction [Doxorubicin results in increased secretion of SFRP1 protein] CTD PMID:30377735 calciol increases expression ISO RGD:735755 6480464 Cholecalciferol results in increased expression of SFRP1 mRNA CTD PMID:17170073 carbamazepine affects expression ISO RGD:735754 6480464 Carbamazepine affects the expression of SFRP1 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:735755 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:735754 6480464 Nanotubes, Carbon results in increased expression of SFRP1 mRNA CTD PMID:25511174 CGP 52608 multiple interactions ISO RGD:735754 6480464 CGP 52608 promotes the reaction [RORA protein binds to SFRP1 gene] CTD PMID:28238834 chloropicrin increases expression ISO RGD:735754 6480464 chloropicrin results in increased expression of SFRP1 mRNA CTD PMID:26352163 chlorpyrifos decreases expression ISO RGD:735755 6480464 Chlorpyrifos results in decreased expression of SFRP1 mRNA CTD PMID:37019170 choline affects expression ISO RGD:735754 6480464 Choline affects the expression of SFRP1 mRNA CTD PMID:17616785 cisplatin decreases expression ISO RGD:735754 6480464 Cisplatin results in decreased expression of SFRP1 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO RGD:735754 6480464 cobaltous chloride results in decreased expression of SFRP1 mRNA CTD PMID:19320972 CU-O LINKAGE decreases expression ISO RGD:735754 6480464 cupric oxide results in decreased expression of SFRP1 mRNA CTD PMID:22077320 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of SFRP1 mRNA CTD PMID:26577399 , PMID:27523638 cytarabine increases expression ISO RGD:735754 6480464 Cytarabine results in increased expression of SFRP1 mRNA CTD PMID:21198554 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of SFRP1 mRNA CTD PMID:23640034 dexamethasone increases expression ISO RGD:735754 6480464 Dexamethasone results in increased expression of SFRP1 mRNA CTD PMID:16144937 dexamethasone multiple interactions ISO RGD:735755 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of SFRP1 mRNA CTD PMID:16054899 diarsenic trioxide increases expression ISO RGD:735754 6480464 Arsenic Trioxide results in increased expression of SFRP1 mRNA, Arsenic Trioxide results in increased expression of SFRP1 protein CTD PMID:26966376 , PMID:28565807 diarsenic trioxide decreases methylation ISO RGD:735754 6480464 Arsenic Trioxide results in decreased methylation of SFRP1 gene, Arsenic Trioxide results in decreased methylation of SFRP1 promoter CTD PMID:26966376 , PMID:28565807 diuron decreases expression EXP 6480464 Diuron results in decreased expression of SFRP1 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:735754 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:735754 6480464 Doxorubicin results in decreased expression of SFRP1 mRNA CTD PMID:29803840 doxorubicin multiple interactions EXP 6480464 3-aminobenzamide inhibits the reaction [SFRP1 protein promotes the reaction [Doxorubicin results in increased cleavage of CASP3 protein]] more ... CTD PMID:30377735 doxorubicin increases response to substance EXP 6480464 SFRP1 protein results in increased susceptibility to Doxorubicin CTD PMID:30377735 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of SFRP1 mRNA CTD PMID:30377735 epoxiconazole increases expression ISO RGD:735755 6480464 epoxiconazole results in increased expression of SFRP1 mRNA CTD PMID:35436446 ethanol increases expression ISO RGD:735754 6480464 Ethanol results in increased expression of SFRP1 mRNA CTD PMID:23378141 ethanol increases expression ISO RGD:735755 6480464 Ethanol results in increased expression of SFRP1 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:735754 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of SFRP1 mRNA CTD PMID:23378141 folic acid multiple interactions ISO RGD:735754 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of SFRP1 mRNA CTD PMID:23378141 folic acid decreases methylation ISO RGD:735754 6480464 Folic Acid results in decreased methylation of SFRP1 promoter CTD PMID:28752528 folic acid multiple interactions ISO RGD:735755 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of SFRP1 mRNA] CTD PMID:22206623 folic acid increases methylation ISO RGD:735754 6480464 Folic Acid deficiency results in increased methylation of SFRP1 promoter CTD PMID:28752528 glycidyl methacrylate decreases expression ISO RGD:735754 6480464 glycidyl methacrylate results in decreased expression of SFRP1 protein CTD PMID:36641056 glyphosate decreases expression EXP 6480464 glyphosate results in decreased expression of SFRP1 mRNA CTD PMID:26302742 heparin multiple interactions EXP 6480464 Heparin promotes the reaction [Doxorubicin results in increased secretion of SFRP1 protein] CTD PMID:30377735 hydroquinone decreases expression ISO RGD:735754 6480464 hydroquinone results in decreased expression of SFRP1 mRNA CTD PMID:31256213 inulin multiple interactions ISO RGD:735755 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SFRP1 mRNA CTD PMID:36331819 lead diacetate affects expression EXP 6480464 lead acetate affects the expression of SFRP1 mRNA CTD PMID:21864555 mercury atom decreases expression ISO RGD:735754 6480464 Mercury results in decreased expression of SFRP1 mRNA CTD PMID:19937285 mercury dibromide decreases expression ISO RGD:735754 6480464 mercuric bromide results in decreased expression of SFRP1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:735754 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SFRP1 mRNA CTD PMID:27188386 mercury(0) decreases expression ISO RGD:735754 6480464 Mercury results in decreased expression of SFRP1 mRNA CTD PMID:19937285 methimazole increases expression EXP 6480464 Methimazole results in increased expression of SFRP1 mRNA CTD PMID:30047161 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of SFRP1 mRNA, Methotrexate results in increased expression of SFRP1 protein CTD PMID:25187349 methotrexate multiple interactions EXP 6480464 Leucovorin inhibits the reaction [Methotrexate results in increased expression of SFRP1 mRNA], Leucovorin inhibits the reaction [Methotrexate results in increased expression of SFRP1 protein] CTD PMID:25187349 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of SFRP1 gene CTD PMID:35440735 methylmercury chloride decreases expression ISO RGD:735754 6480464 methylmercuric chloride results in decreased expression of SFRP1 mRNA CTD PMID:28001369 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of SFRP1 mRNA CTD PMID:34740672 mifepristone increases expression ISO RGD:735754 6480464 Mifepristone results in increased expression of SFRP1 mRNA CTD PMID:17584828 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SFRP1 mRNA CTD PMID:18164116 N-nitrosodiethylamine multiple interactions ISO RGD:735755 6480464 epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in decreased expression of SFRP1 mRNA] more ... CTD PMID:27058323 N-nitrosodiethylamine decreases expression ISO RGD:735755 6480464 Diethylnitrosamine results in decreased expression of SFRP1 mRNA, Diethylnitrosamine results in decreased expression of SFRP1 protein CTD PMID:27058323 naphthalene increases expression ISO RGD:735755 6480464 naphthalene results in increased expression of SFRP1 mRNA CTD PMID:18978301 nickel atom decreases expression ISO RGD:735754 6480464 Nickel results in decreased expression of SFRP1 mRNA CTD PMID:25583101 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SFRP1 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of SFRP1 mRNA CTD PMID:25729387 ozone increases expression ISO RGD:735754 6480464 Ozone results in increased expression of SFRP1 mRNA CTD PMID:23033980 ozone multiple interactions ISO RGD:735755 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SFRP1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SFRP1 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid decreases expression ISO RGD:735754 6480464 p-Chloromercuribenzoic Acid results in decreased expression of SFRP1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:735754 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SFRP1 mRNA CTD PMID:27188386 p-menthan-3-ol increases expression ISO RGD:735754 6480464 Menthol results in increased expression of SFRP1 mRNA CTD PMID:26760959 panobinostat multiple interactions ISO RGD:735754 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SFRP1 mRNA CTD PMID:27188386 panobinostat decreases expression ISO RGD:735754 6480464 panobinostat results in decreased expression of SFRP1 mRNA CTD PMID:26272509 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SFRP1 mRNA CTD PMID:33387578 PCB138 multiple interactions ISO RGD:735755 6480464 [2 more ... CTD PMID:25510870 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:735755 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SFRP1 mRNA CTD PMID:36331819 phenylmercury acetate decreases expression ISO RGD:735754 6480464 Phenylmercuric Acetate results in decreased expression of SFRP1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:735754 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SFRP1 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:735755 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SFRP1 mRNA CTD PMID:23519560 pirinixic acid decreases expression ISO RGD:735755 6480464 pirinixic acid results in decreased expression of SFRP1 mRNA CTD PMID:25270620 pravastatin increases expression ISO RGD:735755 6480464 Pravastatin results in increased expression of SFRP1 mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of SFRP1 mRNA CTD PMID:30047161 quercetin decreases expression ISO RGD:735754 6480464 Quercetin results in decreased expression of SFRP1 mRNA CTD PMID:15309432 rac-lactic acid decreases expression ISO RGD:735754 6480464 Lactic Acid results in decreased expression of SFRP1 mRNA CTD PMID:30851411 resveratrol decreases expression ISO RGD:735754 6480464 resveratrol results in decreased expression of SFRP1 mRNA CTD PMID:12569576 SB 431542 multiple interactions ISO RGD:735754 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos increases expression ISO RGD:735754 6480464 Asbestos, Serpentine results in increased expression of SFRP1 mRNA CTD PMID:21148743 silicon dioxide increases expression ISO RGD:735754 6480464 Silicon Dioxide analog results in increased expression of SFRP1 mRNA CTD PMID:25895662 silicon dioxide decreases expression ISO RGD:735754 6480464 Silicon Dioxide results in decreased expression of SFRP1 mRNA CTD PMID:25351596 , PMID:27095093 silver atom decreases expression ISO RGD:735755 6480464 Silver results in decreased expression of SFRP1 mRNA CTD PMID:27131904 silver atom increases expression ISO RGD:735755 6480464 Silver results in increased expression of SFRP1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:735755 6480464 Silver results in decreased expression of SFRP1 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:735755 6480464 Silver results in increased expression of SFRP1 mRNA CTD PMID:27131904 sodium arsenate increases expression ISO RGD:735755 6480464 sodium arsenate results in increased expression of SFRP1 mRNA CTD PMID:21795629 sodium arsenate multiple interactions ISO RGD:735754 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SFRP1 mRNA CTD PMID:32525701 Soman increases expression EXP 6480464 Soman results in increased expression of SFRP1 mRNA CTD PMID:19281266 sporidesmin A multiple interactions ISO RGD:735754 6480464 MIR31 mRNA affects the reaction [sporidesmin results in decreased expression of SFRP1 mRNA] CTD PMID:28193462 sporidesmin A decreases expression ISO RGD:735754 6480464 sporidesmin results in decreased expression of SFRP1 mRNA CTD PMID:28193462 sulforaphane increases expression ISO RGD:735755 6480464 sulforaphane results in increased expression of SFRP1 mRNA CTD PMID:30529165 sunitinib decreases expression ISO RGD:735754 6480464 Sunitinib results in decreased expression of SFRP1 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:735755 6480464 Tamoxifen affects the expression of SFRP1 mRNA CTD PMID:17555576 temozolomide increases expression ISO RGD:735754 6480464 Temozolomide results in increased expression of SFRP1 mRNA CTD PMID:31758290 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SFRP1 mRNA CTD PMID:31150632 theaflavin multiple interactions ISO RGD:735755 6480464 theaflavin inhibits the reaction [Diethylnitrosamine results in decreased expression of SFRP1 mRNA], theaflavin inhibits the reaction [Diethylnitrosamine results in decreased expression of SFRP1 protein] CTD PMID:27058323 thimerosal decreases expression ISO RGD:735754 6480464 Thimerosal results in decreased expression of SFRP1 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SFRP1 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:735755 6480464 titanium dioxide results in increased expression of SFRP1 mRNA CTD PMID:23557971 , PMID:27760801 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SFRP1 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of SFRP1 mRNA CTD PMID:25729387 topotecan affects response to substance ISO RGD:735754 6480464 SFRP1 protein affects the susceptibility to Topotecan CTD PMID:16217747 trichostatin A multiple interactions ISO RGD:735754 6480464 [Decitabine co-treated with trichostatin A] results in increased expression of SFRP1 mRNA more ... CTD PMID:17923031 , PMID:27188386 trichostatin A decreases expression ISO RGD:735754 6480464 trichostatin A results in decreased expression of SFRP1 mRNA CTD PMID:24935251 , PMID:26272509 valproic acid decreases methylation ISO RGD:735754 6480464 Valproic Acid results in decreased methylation of SFRP1 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:735754 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SFRP1 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:735754 6480464 Valproic Acid results in decreased expression of SFRP1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:735754 6480464 Valproic Acid affects the expression of SFRP1 mRNA CTD PMID:25979313 vancomycin increases expression ISO RGD:735755 6480464 Vancomycin results in increased expression of SFRP1 mRNA CTD PMID:18930951 vorinostat multiple interactions ISO RGD:735754 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SFRP1 mRNA CTD PMID:27188386 vorinostat decreases expression ISO RGD:735754 6480464 vorinostat results in decreased expression of SFRP1 mRNA CTD PMID:26272509 , PMID:27188386 XL147 multiple interactions ISO RGD:735755 6480464 XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SFRP1 mRNA] CTD PMID:29891994 zaragozic acid A affects expression ISO RGD:735755 6480464 squalestatin 1 affects the expression of SFRP1 mRNA CTD PMID:27225895 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of SFRP1 mRNA CTD PMID:27225895
